Rafferty Asset Management, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 138 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,552,741
+50.0%
913,301
+31.1%
0.02%
+20.0%
Q4 2022$2,368,664
-35.1%
696,666
+4.3%
0.02%
-48.7%
Q3 2022$3,647,000
+76.0%
668,004
+45.4%
0.04%
+105.3%
Q2 2022$2,072,000
-65.2%
459,409
-43.2%
0.02%
-45.7%
Q1 2022$5,962,000
+143.6%
808,939
+112.6%
0.04%
+169.2%
Q4 2021$2,447,000
+13.3%
380,568
+2.6%
0.01%
-13.3%
Q3 2021$2,159,000
-17.2%
370,983
+46.8%
0.02%
-6.2%
Q2 2021$2,609,000
-8.4%
252,764
-6.6%
0.02%
-15.8%
Q1 2021$2,847,000
+212.2%
270,663
+359.3%
0.02%
+111.1%
Q4 2020$912,000
-55.3%
58,933
-57.8%
0.01%
-64.0%
Q3 2020$2,040,000
+88.4%
139,729
+144.4%
0.02%
+66.7%
Q2 2020$1,083,000
+353.1%
57,177
+360.2%
0.02%
+50.0%
Q1 2020$239,000
-88.2%
12,425
-88.2%
0.01%
-67.7%
Q4 2019$2,025,000
+7.1%
105,657
-46.3%
0.03%
+3.3%
Q3 2019$1,891,000196,6110.03%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,561,052$26,245,0005.86%
Palo Alto Investors LP 5,621,533$41,431,0003.20%
Iron Triangle Partners LP 2,000,000$14,740,0001.75%
Altium Capital Management LP 645,000$4,754,0001.59%
Birchview Capital, LP 269,332$1,985,0001.43%
Rubric Capital Management LP 3,607,443$26,587,0000.96%
Lombard Odier Asset Management (Switzerland) SA 776,053$5,720,0000.45%
RICE HALL JAMES & ASSOCIATES, LLC 1,344,929$9,912,0000.40%
Golden State Equity Partners 41,850$308,0000.16%
Hennion & Walsh Asset Management, Inc. 385,837$2,844,0000.15%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders